Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global Throat Cancer Therapeutics Market Size, Status and Forecast 2019-2025

Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer f...

$3,900.00 16 August, 2019 | QYResearch

Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in whic...

Pharma & Healthcare

Global Molecular Biology Enzymes, Kits, and Reagents Market Size, Status and Forecast 2019-2025

Enzymes are macromolecular biological catalysts that accelerate chemical reactions. Molecular biology enzymes, kits, and reagents are extensively used in bio...

$3,900.00 16 August, 2019 | QYResearch

Enzymes are macromolecular biological catalysts that accelerate chemical reactions. Molecular biology enzymes, kits, and reagents are extensively u...

Pharma & Healthcare

Global Splenomegaly Therapeutics Market Size, Status and Forecast 2019-2025

Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of the four c...

$3,900.00 16 August, 2019 | QYResearch

Splenomegaly is an enlargement of the spleen.The spleen usually lies in the left upper quadrant (LUQ) of the human abdomen. Splenomegaly is one of ...

Pharma & Healthcare

Global Gynecological Cancers Therapeutics Market Size, Status and Forecast 2019-2025

Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five...

$3,900.00 16 August, 2019 | QYResearch

Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups...

Pharma & Healthcare

Global Esophageal Cancer Drugs Market Size, Status and Forecast 2019-2025

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallo...

$3,900.00 16 August, 2019 | QYResearch

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty...

Pharma & Healthcare

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2019-2025

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all ...

$3,900.00 16 August, 2019 | QYResearch

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 8...

Pharma & Healthcare

Global (United States, European Union and China) Combined hormonal contraceptive Market Research Report 2019-2025

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Co...

$3,280.00 16 August, 2019 | QYResearch

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregn...

Pharma & Healthcare

Global (United States, European Union and China) Microcarrier Market Research Report 2019-2025

A microcarrier is a support matrix allowing for the growth of adherent cells in bioreactors. In 2017, Europe dominated the global microcarriers market. Growt...

$3,280.00 16 August, 2019 | QYResearch

A microcarrier is a support matrix allowing for the growth of adherent cells in bioreactors. In 2017, Europe dominated the global microcarriers mar...

Pharma & Healthcare

Global (United States, European Union and China) Acute Intermittent Porphyria Drugs Market Research Report 2019-2025

Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic dis...

$3,280.00 16 August, 2019 | QYResearch

Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant met...

Pharma & Healthcare

Global (United States, European Union and China) Benazepril Market Research Report 2019-2025

Benazepril is an ACE inhibitor used primarily to treat high blood pressure, congestive heart failure and heart disease, as well as kidney and retinal complic...

$3,280.00 16 August, 2019 | QYResearch

Benazepril is an ACE inhibitor used primarily to treat high blood pressure, congestive heart failure and heart disease, as well as kidney and retin...